Back to Search
Start Over
Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.
- Source :
-
Journal of hepatology [J Hepatol] 2011 Nov; Vol. 55 (5), pp. 1086-94. Date of Electronic Publication: 2011 Feb 24. - Publication Year :
- 2011
-
Abstract
- Background & Aims: The identification of the cellular and molecular pathways that mediate the development of non-alcoholic steatohepatitis is of crucial importance. Cytokines produced by liver-resident and infiltrating inflammatory cells, play a pivotal role in liver inflammation. The role of the proinflammatory cytokines IL-1α and IL-1β in steatohepatitis remains elusive.<br />Methods: We employed IL-1α and IL-1β-deficient mice and transplanted marrow cells to study the role of liver-resident and bone marrow-derived IL-1 in steatosis and its progression to steatohepatitis.<br />Results: Atherogenic diet-induced steatohepatitis in wild-type mice was associated with 16 and 4.6 fold-elevations in mRNA levels of hepatic IL-1α and IL-1β, respectively. In mice deficient in either IL-1α or IL-1β the transformation of steatosis to steatohepatitis and liver fibrosis was markedly reduced. This protective effect in IL-1α-deficient mice was noted despite increased liver cholesterol levels. Deficiency of IL-1α markedly reduced plasma serum amyloid A and steady-state levels of mRNA coding for inflammatory genes (P-selectin, CXCL1, IL-6, and TNFα) as well as pro-fibrotic genes (MMP-9 and Collagen) and particularly a 50% decrease in TGFβ levels (p = 0.004). IL-1α mRNA levels were two-folds lower in IL-1β-deficient mice, and IL-1β transcripts were three-folds lower in IL-1α-deficient compared to wild-type mice. Hepatic cell derived IL-1α rather than from recruited bone marrow-derived cells was required for steatohepatitis development.<br />Conclusions: These data demonstrate the critical role of IL-1α and IL-1β in the transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. Therefore, the potential of neutralizing IL-1α and/or IL-1β to inhibit the development of steatohepatitis should be explored.<br /> (Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Analysis of Variance
Animals
Chemokine CXCL1 genetics
Chemokine CXCL1 metabolism
Collagen genetics
Collagen metabolism
Diet, Atherogenic
Disease Progression
Fatty Liver pathology
Gene Expression
Hepatitis pathology
Hypercholesterolemia complications
Interleukin-1 genetics
Interleukin-1 metabolism
Interleukin-1alpha genetics
Interleukin-1alpha metabolism
Interleukin-1beta genetics
Interleukin-1beta metabolism
Liver Cirrhosis pathology
Male
Matrix Metalloproteinase 9 genetics
Matrix Metalloproteinase 9 metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
P-Selectin genetics
P-Selectin metabolism
Serum Amyloid A Protein metabolism
Transforming Growth Factor beta genetics
Transforming Growth Factor beta metabolism
Tumor Necrosis Factor-alpha genetics
Tumor Necrosis Factor-alpha metabolism
Fatty Liver metabolism
Hepatitis metabolism
Interleukin-1alpha deficiency
Interleukin-1beta deficiency
Liver Cirrhosis metabolism
RNA, Messenger metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1600-0641
- Volume :
- 55
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 21354232
- Full Text :
- https://doi.org/10.1016/j.jhep.2011.01.048